Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
The aim of this study is to evaluate safety and efficiency of electrocautery de-epithelization in mammoplasty.
Mammoplasty is the fifth most commonly performed by plastic surgeons worldwide to improve symptomatology resulting from macromastia.
One of the key stages in a breast reduction or augmentation surgery is the de-epithelization process. De-epithelialization is the first stage of reduction mammoplasty in techniques that use dermal, dermo-glandular pedicles. Traditional methods of de-epithelization include manual dissection or mechanical scraping as time-consuming and demanding by most surgeons, especially when the breasts are large and when there is no assistant available.
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Electrocautery group | Patients undergoing standard surgical de-epithelization with electrocautery. |
| |
| Control group | Patients undergoing standard surgical de-epithelization using surgical blade by scalpel. |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Electrocautery | Procedure | Patients undergoing standard surgical de-epithelization with electrocautery. |
|
| Measure | Description | Time Frame |
|---|---|---|
| Operative time | Operative time (time taken from skin incision to completion of skin closure). Operative time will be measured for each breast | Intraoperatively |
| Measure | Description | Time Frame |
|---|---|---|
| Degree of pain | Degree of pain will be measured using a standard 10-point visual analog pain scale (VAS). The women verbally reported a pain rating for each breast first in the recovery room (within 4 hours of surgical stop) and again at the first follow-up visit (1 to 3 days after surgery). | 3 days after surgery |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Women undergoing mammoplasty
Not provided
This retrospective study was conducted on 100 females patients aged 18 years or older who were scheduled to undergo mammoplasty at Tanta University Hospitals, Egypt between July 2024 and February 2025
Not provided
Not provided
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Tanta University | Tanta | El-Gharbia | 31527 | Egypt |
The data will be available upon a reasonable request from the corresponding author after the end of study for one year.
The data will be available upon a reasonable request from the corresponding author.
After the end of study for one year.
Not provided
Not provided
| ID | Term |
|---|---|
| D004564 | Electrocoagulation |
| ID | Term |
|---|---|
| D002425 | Cautery |
| D013812 | Therapeutics |
| D055011 | Ablation Techniques |
| D013514 | Surgical Procedures, Operative |
Not provided
Not provided
Not provided
Not provided
Not provided
| Surgical blade by scalpel | Procedure | Patients undergoing standard surgical de-epithelization using surgical blade by scalpel. |
|
| De-epithelization time |
De-epithelization time will be recorded. |
| Intraoperatively |
| Time to achieve hemostasis | The time to achieve hemostasis will be assessed. | Intraoperatively |
| Duration of drain placement | Duration of drain placement will be recorded. | Intraoperatively |
| Blood loss | Blood loss will be assessed by weighing the swabs that will be used during the pedicle de-epithelialization process. | Intraoperatively |
| Wound healing time | Wound healing time will be recorded. | 6 weeks after surgery |
| Incidence of adverse events | The incidence of adverse events such as flap necrosis, hematoma, seroma, and surgical site infection will be recorded. | 6 weeks after surgery |